Login / Signup

Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer.

Yuan GaoYouling LiYunhe ZhuQiao LuoYifeng LuKe WenBoyu DuXueyan XiGang Li
Published in: Current cancer drug targets (2024)
Emodin shows promise as a potential therapeutic agent for HCC by targeting CD44-- positive hepatoma cells.
Keyphrases
  • induced apoptosis
  • papillary thyroid
  • cell cycle arrest
  • nk cells
  • cancer therapy
  • emergency department
  • big data
  • machine learning
  • adverse drug
  • drug induced
  • deep learning
  • electronic health record